International Journal of Antimicrobial Agents

International Journal of Antimicrobial Agents

INT J ANTIMICROB AG
影响因子:4.6
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:NETHERLANDS
出版社:Elsevier
发刊时间:1991
发刊频率:Monthly
收录数据库:SCIE/Scopus收录
ISSN:0924-8579

期刊介绍

The International Journal of Antimicrobial Agents provides comprehensive and up-to-date peer reviewed reference information on the physical, pharmacological, in vitro and clinical properties of individual antimicrobial agents (antiviral agents, antiparasitic agents, antibacterial agents, antifungal agents, etc.). In addition, the journal signals new trends and developments in the field through highly authoritative review articles on antimicrobial agents. Special attention is given to articles providing insight into the problems of antimicrobial resistance both in the hospital and in the community. Both solicited reviews by top experts in the mentioned fields and high-quality original research papers are published.
《国际抗菌药物杂志》提供了关于各种抗菌药物(抗病毒剂、抗寄生虫药、抗菌药物、抗真菌药物等)的物理、药理、体外和临床特性的全面和最新同行评审参考信息。此外,该杂志还通过高度权威的抗菌药物综述文章来显示该领域的新趋势和发展。特别关注的文章提供了对抗菌药物耐药性问题的见解在医院和社区。由上述领域的顶级专家进行的征集评审和高质量的原创研究论文均已发表。
年发文量 238
国人发稿量 68.26
国人发文占比 0.29%
自引率 -
平均录取率0
平均审稿周期 一般,3-8周平均6.5周
版面费 US$3280
偏重研究方向 医学-传染病学
期刊官网 http://www.elsevier.com/wps/find/journaldescription.cws_home/505521/description#description
投稿链接 https://www.editorialmanager.com/IJAA

期刊高被引文献

Antibiotic discovery: history, methods and perspectives.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2018.11.010
Antibacterial and antivirulence activities of auranofin against Clostridium difficile.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2018.09.018
Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria with an emphasis on carbapenems and colistin: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.06.009
High dose trimethoprim-sulfamethoxazole and clindamycin for Staphylococcus aureus endocarditis.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.06.006
Effectiveness of switching from protease inhibitors to dolutegravir in combination with nucleoside reverse transcriptase inhibitors as maintenance antiretroviral therapy among HIV-positive patients.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.03.016
Anti-persister activity of squalamine against Acinetobacter baumannii.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2018.11.004
Short- versus long-course antibiotics in osteomyelitis: A systematic review and meta-analysis.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.01.007
Chemotherapeutic options for the treatment of human trichomoniasis.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2018.10.016
Comparing the selective and co-selective effects of different antimicrobials in bacterial communities
来源期刊:International Journal of Antimicrobial AgentsDOI:10.1016/j.ijantimicag.2019.03.001
Aripiprazole repurposed as an inhibitor of biofilm formation, and sterol biosynthesis in multi-drug resistant Candida albicans.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.05.016
Identification of an anti-Gram-negative bacteria agent disrupting the interaction between lipopolysaccharide transporters LptA and LptC.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2018.11.016
Prediction of bloodstream infection caused by extended-spectrum β-lactamase-producing Enterobacterales in patients with suspected community-onset sepsis.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.02.008
Hot Topics on Vertebral Osteomyelitis from the International Society of Antimicrobial Chemotherapy.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.06.013
Population pharmacokinetic modelling of total and unbound flucloxacillin in non-critically ill patients to devise a rational continuous dosing regimen.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2018.11.018
Daptomycin as adjunctive treatment for experimental infection by Acinetobacter baumannii with resistance to colistin.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2018.10.024
The epidemiology and characterization of carbapenem-non-susceptible Pseudomonas aeruginosa in a large intensive care unit in Jakarta, Indonesia.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.08.003
LABiocin database: a new database designed specifically for Lactic Acid Bacteria bacteriocins.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.07.012
Within-host heterogeneity and flexibility of mcr-1 transmission in chicken gut.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.09.010
In-vitro adsorption and sieving coefficient of ticarcillin-clavulanate during continuous haemofiltration.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.03.018
In vitro evaluation of dinactin, a potent microbial metabolite against Mycobacterium tuberculosis.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2018.09.019
In-vitro studies on a natural lantibiotic, paenibacillin: A new-generation antibacterial drug candidate to overcome multi-drug resistance.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.03.020
Bacteriocin production and distribution of bacteriocin-encoding genes in enterococci from dogs.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.11.016
Recovery of metabolic impairment in patients who cleared chronic hepatitis C infection after direct-acting antiviral therapy.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2018.11.024
Antivirulence activity of auranofin against vancomycin-resistant enterococci: in vitro and in vivo studies.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.10.009
Evaluation of alternative antibiotics for susceptibility of gonococcal isolates from China.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.11.003
Plasma and interstitial fluid population pharmacokinetics of vancomycin in critically ill patients with sepsis.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2018.09.021
Genomic analysis of Staphylococcus aureus along a pork production chain and in the community, Shandong Province, China.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.03.022
Early switching of antibiotic therapy from intravenous to oral using a combination of education, pocket-sized cards and switch advice: A practical intervention resulting in a reduction in length of hospital stay.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.07.020
Risk factors for mortality among patients with Pseudomonas aeruginosa bacteremia - retrospective multicenter study.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.11.004
β-lactam antibiotic versus combined β-lactam antibiotic and single-daily dosing regimens of aminoglycosides for the treatment of serious infections: a meta-analysis: Category: Systematic review and meta-analysis.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.10.020
Longistyline A, a natural stilbene isolated from leaves of Cajanus cajan, exhibits significant anti-MRSA activity.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.10.002
Candida auris in Singapore: Genomic Epidemiology, Antifungal Drug Resistance and Identification using the updated 8.01 VITEK®2 System.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.09.016
Ceftazidime-avibactam versus carbapenems for the treatment of infections caused by Enterobacteriaceae: a meta-analysis of randomized controlled trials.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.09.007
Isovalerylshikonin, a new resistance-modifying agent from Arnebia euchroma, supresses antimicrobial resistance of drug-resistant Staphylococcus aureus.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2018.08.021
Synergistic and bactericidal activities of mecillinam, amoxicillin and clavulanic acid combinations against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in 24-h time-kill experiments.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2018.09.011
Catalysing the way towards antimicrobial effectiveness: A systematic analysis and a new online resource for antimicrobial-enzyme combinations against Pseudomonas aeruginosa and Staphylococcus aureus.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.01.001
Pharmacokinetics of pyrazinamide during the initial phase of tuberculous meningitis treatment.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.06.010
Identification and characterization of novel isothiazolones with potent bactericidal activity against multi-drug resistant Acinetobacter baumannii clinical isolates.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2018.12.007
Colistin-containing cement spacer for treatment of experimental carbapenemase-producing Klebsiella pneumoniae prosthetic joint infection.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.07.009
Development of a target-free high throughput screening platform for the discovery of anti-leishmanial compounds.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.07.013
Cellular pharmacokinetics and intracellular activity of the bacterial fatty acid synthesis inhibitor afabicin desphosphono against different resistance phenotypes of Staphylococcus aureus in models of cultured phagocytic cells.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.11.005
Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trials.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.01.016
SURVIVAL BENEFIT ASSOCIATED WITH CLARITHROMYCIN IN SEVERE COMMUNITY-ACQUIRED PNEUMONIA: A MATCHED COMPARATOR STUDY.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.10.017
Outcomes of treating AmpC producing Enterobacterales bacteraemia with Carbapenems versus Non-carbapenems.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.105860
Treatment of chronic hepatitis due to Hepatitis B with Delta virus coinfection.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.09.012
Population pharmacokinetics of ticarcillin in critically ill patients receiving extended daily diafiltration.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.06.027
β-lactam antibiotics vs. vancomycin for the early treatment of enterococcal bacteraemia: A retrospective cohort study.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.03.023
Clinical outcomes following treatment of Enterobacter species pneumonia with piperacillin/tazobactam compared to cefepime or ertapenem.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.07.008
Efficacy of antiretroviral compounds against Toxoplasma gondii in vitro.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.08.023
Change of antimicrobial susceptibility and PCR ribotypes of Clostridioides difficile in a hospital over 5 years: correlation analyses with antimicrobial consumption.
来源期刊:International journal of antimicrobial agentsDOI:10.1016/j.ijantimicag.2019.05.022

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
91.60%32.57%-1.39%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q1区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
INFECTIOUS DISEASES
Q1

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学2区
PHARMACOLOGY & PHARMACY 药学
1区
INFECTIOUS DISEASES 传染病学
2区
MICROBIOLOGY 微生物学
2区
2023年12月升级版
医学2区
INFECTIOUS DISEASES 传染病学
2区
MICROBIOLOGY 微生物学
2区
PHARMACOLOGY & PHARMACY 药学
2区
2022年12月旧的升级版
医学2区
INFECTIOUS DISEASES 传染病学
2区
MICROBIOLOGY 微生物学
2区
PHARMACOLOGY & PHARMACY 药学
2区